Welcome to the Daily Pharma Scoop, a daily feature from the creators of the Total Pharma Tracker, a popular biopharma Marketplace service here on Seeking Alpha. In the daily scoop, we focus in on one key investment concept from the biopharma space and also provide quick commentary on other important news and a set of selected links to major news from the day before.
Galectin up on positive early-stage data
Discussion: On September 20, Galectin Therapeutics (GALT) announced preliminary Phase 1b data from a clinical trial evaluating a combination therapy of its